Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 4, Issue 8 (2015)

Investigation of the psychopharmacological profile of mianserin, A 5-ht2a/2c receptor antagonist

Author(s):
Dr. Somnth M Matule and Dr. SA Jadhav
Abstract:
Results: Mianserin at 1.25, 2.5 and 5 mg/kg i.p. did significantly antagonise 5-HT2C receptor agonist fluoxetine induced PEs and 10 and 20 mg/kg i.p. mianserin abolished fluoxetine induced PEs. Thus 1.25 to 20 mg/kg doses of mianserin possess significant 5-HT2C receptor blocking activity. Mianserin at 5, 10 and 20 mg/kg i.p. doses does not block presynaptic D2 DA autoreceptors as with these doses it failed to antagonise low dose (0.1 mg/kg) apomorphine induced catalepsy. Mianserin at 5, 10 and 20 mg/kg i.p. doses is devoid of postsynaptic D2 and D1 DA receptor blocking activity as at these doses it did not antagonise apomorphine induced SB and did not produce catalepsy in rats. Conclusion: Mianserin at 5, 10 and 20 mg/kg doses blocks the 5-HT2C receptors on the nigrostriatal DAergic neurons and remove the inhibitory influence of 5-HT on the nigrostriatal DAergic neurons which further causes increase in intraneuronal synthesis of DA and hence intraneuronal stores of DA. So pretreatment with 5, 10 and 20 mg/kg i.p. makes more DA available for release and resultant potentiation of dexamphetamine SB and antagonism of haloperidol catalepsy.
Pages: 140-143  |  540 Views  81 Downloads


The Pharma Innovation Journal
How to cite this article:
Dr. Somnth M Matule, Dr. SA Jadhav. Investigation of the psychopharmacological profile of mianserin, A 5-ht2a/2c receptor antagonist. Pharma Innovation 2015;4(8):140-143.

Call for book chapter